A PERSONAL DECISION

If it's true that the early bird gets the worm, then the latecomers need to have some special tactics to ensure they don't go hungry.In the vaginal yeast infection treatment category, the early birds, Ortho Pharmaceutical's Monistat 7 and Gyne-Lotrimin from Schering-Plough Healthcare, literally flew off the shelves and amassed huge market shares when the active ingredients in their products went over-the-counter

If it's true that the early bird gets the worm, then the latecomers need to have some special tactics to ensure they don't go hungry.

In the vaginal yeast infection treatment category, the early birds, Ortho Pharmaceutical's Monistat 7 and Gyne-Lotrimin from Schering-Plough Healthcare, literally flew off the shelves and amassed huge market shares when the active ingredients in their products went over-the-counter about three years ago.

The market innovators, Monistat 7 and Gyn

Register to view the full article

Already a member? .